{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T05:44:26Z","timestamp":1783748666730,"version":"3.55.0"},"reference-count":29,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2016,7,8]],"date-time":"2016-07-08T00:00:00Z","timestamp":1467936000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"funder":[{"name":"NIH Intramural Research Program"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0158505","type":"journal-article","created":{"date-parts":[[2016,7,8]],"date-time":"2016-07-08T18:33:41Z","timestamp":1468002821000},"page":"e0158505","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":8,"title":["Beyond Oncolytics: E1B55K-Deleted Adenovirus as a Vaccine Delivery Vector"],"prefix":"10.1371","volume":"11","author":[{"given":"Michael A.","family":"Thomas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tinashe","family":"Nyanhete","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iskra","family":"Tuero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Venzon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marjorie","family":"Robert-Guroff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2016,7,8]]},"reference":[{"issue":"9","key":"ref1","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1517\/14712598.8.9.1347","article-title":"Replicating adenovirus vector prime\/protein boost strategies for HIV vaccine development","volume":"8","author":"LJ Patterson","year":"2008","journal-title":"Expert Opin Biol Ther"},{"issue":"6","key":"ref2","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/nm0697-651","article-title":"Long-term protection of chimpanzees against high-dose HIV-1 challenge induced by immunization","volume":"3","author":"MD Lubeck","year":"1997","journal-title":"Nat Med"},{"issue":"12","key":"ref3","doi-asserted-by":"crossref","first-page":"10275","DOI":"10.1128\/JVI.72.12.10275-10280.1998","article-title":"Vaccine protection against a heterologous, non-syncytium-inducing, primary human immunodeficiency virus","volume":"72","author":"M Robert-Guroff","year":"1998","journal-title":"J Virol"},{"issue":"5","key":"ref4","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1128\/JVI.78.5.2212-2221.2004","article-title":"Protection against mucosal simian immunodeficiency virus SIV(mac251) challenge by using replicating adenovirus-SIV multigene vaccine priming and subunit boosting","volume":"78","author":"LJ Patterson","year":"2004","journal-title":"J Virol"},{"issue":"1","key":"ref5","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.virol.2006.05.012","article-title":"Durable protection of rhesus macaques immunized with a replicating adenovirus-SIV multigene prime\/protein boost vaccine regimen against a second SIVmac251 rectal challenge: role of SIV-specific CD8+ T cell responses","volume":"353","author":"NV Malkevitch","year":"2006","journal-title":"Virology"},{"issue":"7","key":"ref6","doi-asserted-by":"crossref","first-page":"3414","DOI":"10.1128\/JVI.02453-06","article-title":"A replication-competent adenovirus-human immunodeficiency virus (Ad-HIV) tat and Ad-HIV env priming\/Tat and envelope protein boosting regimen elicits enhanced protective efficacy against simian\/human immunodeficiency virus SHIV89.6P challenge in rhesus macaques","volume":"81","author":"T Demberg","year":"2007","journal-title":"J Virol"},{"issue":"2","key":"ref7","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.virol.2008.09.016","article-title":"Systemic neutralizing antibodies induced by long interval mucosally primed systemically boosted immunization correlate with protection from mucosal SHIV challenge","volume":"382","author":"WM Bogers","year":"2008","journal-title":"Virology"},{"issue":"2","key":"ref8","doi-asserted-by":"crossref","first-page":"e31177","DOI":"10.1371\/journal.pone.0031177","article-title":"Pre-clinical evaluation of a replication-competent recombinant adenovirus serotype 4 vaccine expressing influenza H5 hemagglutinin","volume":"7","author":"J Alexander","year":"2012","journal-title":"PLoS One"},{"key":"ref9","article-title":"Safety and immunogenicity of an oral, replicating adenovirus serotype 4 vector vaccine for H5N1 influenza: a randomised, double-blind, placebo-controlled, phase 1 study","author":"M Gurwith","year":"2013","journal-title":"Lancet Infect Dis"},{"issue":"12","key":"ref10","doi-asserted-by":"crossref","first-page":"e82380","DOI":"10.1371\/journal.pone.0082380","article-title":"Pre-clinical development of a recombinant, replication-competent adenovirus serotype 4 vector vaccine expressing HIV-1 envelope 1086 clade C","volume":"8","author":"J Alexander","year":"2013","journal-title":"PLoS One"},{"issue":"5","key":"ref11","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1093\/jnci\/djj111","article-title":"China approves world's first oncolytic virus therapy for cancer treatment","volume":"98","author":"K Garber","year":"2006","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"ref12","doi-asserted-by":"crossref","first-page":"133","DOI":"10.2174\/156800907780058862","article-title":"From ONYX-015 to armed vaccinia viruses: the education and evolution of oncolytic virus development","volume":"7","author":"AM Crompton","year":"2007","journal-title":"Curr Cancer Drug Targets"},{"issue":"24","key":"ref13","doi-asserted-by":"crossref","first-page":"11427","DOI":"10.1128\/JVI.74.24.11427-11436.2000","article-title":"Expression and characterization of a single-chain polypeptide analogue of the human immunodeficiency virus type 1 gp120-CD4 receptor complex","volume":"74","author":"TR Fouts","year":"2000","journal-title":"J Virol"},{"issue":"10","key":"ref14","doi-asserted-by":"crossref","first-page":"e76344","DOI":"10.1371\/journal.pone.0076344","article-title":"Effects of the deletion of early region 4 (E4) open reading frame 1 (orf1), orf1-2, orf1-3 and orf1-4 on virus-host cell interaction, transgene expression, and immunogenicity of replicating adenovirus HIV vaccine vectors","volume":"8","author":"MA Thomas","year":"2013","journal-title":"PLoS One"},{"key":"ref15","first-page":"471","article-title":"HIV-1 CD4-induced (CD4i) gp120 epitope vaccines promote B and T-cell responses that contribute to reduced viral loads in rhesus macaques","author":"MA Thomas","year":"2014","journal-title":"Virology"},{"issue":"8","key":"ref16","doi-asserted-by":"crossref","first-page":"3591","DOI":"10.1128\/JVI.02269-08","article-title":"The adenoviral E1B 55-kilodalton protein controls expression of immune response genes but not p53-dependent transcription","volume":"83","author":"DL Miller","year":"2009","journal-title":"J Virol"},{"issue":"11","key":"ref17","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1084\/jem.20050240","article-title":"Adenovirus serotype 5 E1A sensitizes tumor cells to NKG2D-dependent NK cell lysis and tumor rejection","volume":"202","author":"JM Routes","year":"2005","journal-title":"J Exp Med"},{"issue":"9","key":"ref18","doi-asserted-by":"crossref","first-page":"4585","DOI":"10.1128\/JVI.02251-07","article-title":"Adenovirus E3\/19K promotes evasion of NK cell recognition by intracellular sequestration of the NKG2D ligands major histocompatibility complex class I chain-related proteins A and B","volume":"82","author":"BP McSharry","year":"2008","journal-title":"J Virol"},{"issue":"1","key":"ref19","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.0105-2896.2010.00893.x","article-title":"Effect of NKG2D ligand expression on host immune responses","volume":"235","author":"M Champsaur","year":"2010","journal-title":"Immunol Rev"},{"issue":"10","key":"ref20","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1128\/MCB.5.10.2552","article-title":"Adenovirus E1B proteins are required for accumulation of late viral mRNA and for effects on cellular mRNA translation and transport","volume":"5","author":"LE Babiss","year":"1985","journal-title":"Mol Cell Biol"},{"issue":"9","key":"ref21","doi-asserted-by":"crossref","first-page":"7474","DOI":"10.1128\/JVI.73.9.7474-7488.1999","article-title":"Roles for the E4 orf6, orf3, and E1B 55-kilodalton proteins in cell cycle-independent adenovirus replication","volume":"73","author":"FD Goodrum","year":"1999","journal-title":"J Virol"},{"issue":"6","key":"ref22","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1128\/JVI.01972-08","article-title":"E4orf1 limits the oncolytic potential of the E1B-55K deletion mutant adenovirus","volume":"83","author":"MA Thomas","year":"2009","journal-title":"J Virol"},{"issue":"1","key":"ref23","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/0042-6822(87)90441-7","article-title":"Adenovirus proteins from both E1B reading frames are required for transformation of rodent cells by viral infection and DNA transfection","volume":"156","author":"DD Barker","year":"1987","journal-title":"Virology"},{"issue":"1","key":"ref24","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1084\/jem.165.1.64","article-title":"IgG2a restriction of murine antibodies elicited by viral infections","volume":"165","author":"JP Coutelier","year":"1987","journal-title":"J Exp Med"},{"issue":"10","key":"ref25","doi-asserted-by":"crossref","first-page":"5911","DOI":"10.1128\/JVI.67.10.5911-5921.1993","article-title":"Packaging capacity and stability of human adenovirus type 5 vectors","volume":"67","author":"AJ Bett","year":"1993","journal-title":"J Virol"},{"issue":"1","key":"ref26","first-page":"12","article-title":"Hepatitis C virus-specific cellular and humoral immune responses following immunization with a multi-epitope fusion protein","volume":"29","author":"F Qiu","year":"2012","journal-title":"Int J Mol Med"},{"issue":"5","key":"ref27","doi-asserted-by":"crossref","first-page":"3041","DOI":"10.1128\/IAI.69.5.3041-3047.2001","article-title":"Improved immunogenicity and protective efficacy of a tuberculosis DNA vaccine encoding Ag85 by protein boosting","volume":"69","author":"A Tanghe","year":"2001","journal-title":"Infect Immun"},{"issue":"9","key":"ref28","doi-asserted-by":"crossref","first-page":"3124","DOI":"10.1073\/pnas.0303709101","article-title":"E1A and E1B proteins inhibit inflammation induced by adenovirus","volume":"101","author":"J Schaack","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"ref29","doi-asserted-by":"crossref","first-page":"3230","DOI":"10.1182\/blood-2010-10-312751","article-title":"CD8+CD44(hi) but not CD4+CD44(hi) memory T cells mediate potent graft antilymphoma activity without GVHD","volume":"117","author":"S Dutt","year":"2011","journal-title":"Blood"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0158505","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,23]],"date-time":"2020-09-23T17:50:57Z","timestamp":1600883457000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0158505"}},"subtitle":[],"editor":[{"given":"Marta M.","family":"Alonso","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,7,8]]},"references-count":29,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2016,7,8]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0158505","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,8]]}}}